Integral-Omics: serial extraction and profiling of metabolome, lipidome, genome, transcriptome, whole proteome and phosphoproteome using biopsy tissue

Wei Li,Jing Sun,Rui Sun,Yujuan Wei,Junke Zheng,Yi Judy Zhu,Tiannan Guo
DOI: https://doi.org/10.1101/2024.09.27.614689
2024-09-28
Abstract:The integrative multi-omics characterization of minute amount of clinical tissue specimens has become increasingly important. Here, we present an approach called Integral-Omics, which enables sequential extraction of metabolites, lipids, genomic DNA, total RNA, proteins, and phosphopeptides from a single biopsy-level tissue specimen. We benchmarked this method with various samples and applied the workflow to perform multi-omics profiling of tissues from six patients with colorectal cancer and found that tumor tissues exhibited suppressed ferroptosis pathway at multi-omics levels. Together, this study presents a methodology that enables sequential extraction and profiling of metabolomics, lipidomics, genomics, transcriptomics, proteomics and phosphoproteomics using biopsy tissue specimens.
Biochemistry
What problem does this paper attempt to address?
The paper aims to address the issue of conducting comprehensive multi-omics analysis from a small number of clinical tissue samples. Specifically, the authors propose a method called "Integral-Omics," which can sequentially extract metabolomics, lipidomics, genomics, transcriptomics, proteomics, and phosphoproteomics from a single biopsy-level tissue sample. This method is particularly suitable for early disease research with small sample sizes, as these samples are usually small in volume (<20 mg) and difficult to analyze using traditional multi-omics methods. ### Main Issues: 1. **Sample Limitation in Multi-Omics Analysis**: Traditional multi-omics analysis methods usually require dividing the sample into multiple parts to extract different biomolecules. This approach is feasible for larger samples (such as late-stage tumor tissues) but not suitable for small biopsy tissue samples. 2. **Limitations of Existing Methods**: Existing multi-omics extraction methods either can only extract a limited number of omics layers or rely on commercial kits and specialized instruments, making it difficult to maintain high efficiency and high-quality data extraction from small sample sizes. ### Solution: - **Integral-Omics Method**: The authors developed a new multi-omics workflow that can sequentially extract various biomolecules from the same small sample in a single experiment. This method includes: - Using a modified Matyash method (MTBE/methanol/DEPC water) for co-extraction of lipids and metabolites. - Releasing RNA and proteins through ice-bath sonication and extracting DNA using the phenol/chloroform/isoamyl alcohol method. - Further processing and analyzing the extracted RNA, proteins, and phosphopeptides. ### Application Validation: - **Benchmarking**: The authors compared the Integral-Omics method with independent extraction methods and commercial multi-omics extraction kits. The results showed that the Integral-Omics method performed excellently in extracting various omics data, with data quality and integrity comparable to independent extraction methods. - **Clinical Application**: The authors used this method to perform multi-omics analysis on tumor tissues and adjacent normal tissues from 6 colorectal cancer patients. They successfully extracted metabolites, lipids, genomic DNA, total RNA, proteins, and phosphopeptides, and discovered that the ferroptosis pathway was inhibited in tumor tissues. ### Conclusion: The Integral-Omics method provides an efficient and reliable approach for comprehensive multi-omics analysis from a small number of clinical tissue samples, particularly suitable for early disease research and the development of personalized medical strategies. This method not only improves experimental efficiency but also ensures the quality and integrity of the data, holding significant clinical application prospects.